Literature DB >> 22242891

Improved synthesis of lysine- and arginine-derived Amadori and Heyns products and in vitro measurement of their angiotensin I-converting enzyme inhibitory activity.

Sudhanva M Srinivas1, Nanishankar V Harohally.   

Abstract

The L-lysine- and L-arginine-derived Amadori and Heyns products consisting of N-(1-deoxy-d-fructos-1-yl)amino acid and N-(2-deoxy-d-glucos-2-yl)amino acid were prepared by reaction of d-fructose and d-glucose with l-lysine hydrochloride and l-arginine hydrochloride using commercial zinc powder as deprotonating reagent and also as catalyst precursor in a simple synthetic route in high yield. These compounds were screened for angiotensin I-converting enzyme (ACE) inhibitory activity using a high-throughput colorimetric assay (utilizing porcine kidney ACE). The IC(50) values fall in the range of 1030-1175 μM, with N(α)-(1-deoxy-d-fructos-1-yl)arginine showing the best IC(50) value (1030 ± 38 μM). This study demonstrates an improved synthetic method for simple Amadori and Heyns products and their moderate ACE inhibitor activity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22242891     DOI: 10.1021/jf204185y

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  2 in total

1.  Solid-phase synthesis of D-fructose-derived Heyns peptides utilizing Nα-Fmoc-Lysin[Nε-(2-deoxy-D-glucos-2-yl),Nε-Boc]-OH as building block.

Authors:  Sebastian Schmutzler; Daniel Knappe; Andreas Marx; Ralf Hoffmann
Journal:  Amino Acids       Date:  2021-05-02       Impact factor: 3.520

2.  Fructose-asparagine is a primary nutrient during growth of Salmonella in the inflamed intestine.

Authors:  Mohamed M Ali; David L Newsom; Juan F González; Anice Sabag-Daigle; Christopher Stahl; Brandi Steidley; Judith Dubena; Jessica L Dyszel; Jenee N Smith; Yakhya Dieye; Razvan Arsenescu; Prosper N Boyaka; Steven Krakowka; Tony Romeo; Edward J Behrman; Peter White; Brian M M Ahmer
Journal:  PLoS Pathog       Date:  2014-06-26       Impact factor: 6.823

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.